159 related articles for article (PubMed ID: 8895995)
1. Neurobiology of L-DOPAergic systems.
Misu Y; Goshima Y; Ueda H; Okamura H
Prog Neurobiol; 1996 Aug; 49(5):415-54. PubMed ID: 8895995
[TBL] [Abstract][Full Text] [Related]
2. L-DOPA systems for blood pressure regulation in the lower brainstem.
Misu Y; Yue JL; Goshima Y
Neurosci Res; 1995 Sep; 23(2):147-58. PubMed ID: 8532212
[TBL] [Abstract][Full Text] [Related]
3. L-dopaergic components in the caudal ventrolateral medulla in baroreflex neurotransmission.
Miyamae T; Goshima Y; Yue JL; Misu Y
Neuroscience; 1999; 92(1):137-49. PubMed ID: 10392837
[TBL] [Abstract][Full Text] [Related]
4. Baroreceptor-aortic nerve-mediated release of endogenous L-3,4-dihydroxyphenylalanine and its tonic depressor function in the nucleus tractus solitarii of rats.
Yue JL; Okamura H; Goshima Y; Nakamura S; Geffard M; Misu Y
Neuroscience; 1994 Sep; 62(1):145-61. PubMed ID: 7816196
[TBL] [Abstract][Full Text] [Related]
5. Altered L-DOPA systems for blood pressure regulation in the lower brainstem of spontaneously hypertensive rats.
Misu Y; Yue JL; Miyamae T; Goshima Y
Hypertens Res; 1995 Dec; 18(4):267-77. PubMed ID: 8747304
[TBL] [Abstract][Full Text] [Related]
6. GABA may function tonically via GABA(A) receptors to inhibit hypotension and bradycardia by L-DOPA microinjected into depressor sites of the nucleus tractus solitarii in anesthetized rats.
Honjo K; Goshima Y; Miyamae T; Misu Y
Neurosci Lett; 1999 Feb; 261(1-2):93-6. PubMed ID: 10081935
[TBL] [Abstract][Full Text] [Related]
7. An L-dopaergic relay from the posterior hypothalamic nucleus to the rostral ventrolateral medulla and its cardiovascular function in anesthetized rats.
Nishihama M; Miyamae T; Goshima Y; Okumura F; Misu Y
Neuroscience; 1999; 92(1):123-35. PubMed ID: 10392836
[TBL] [Abstract][Full Text] [Related]
8. Altered basal release and depressor effect of L-DOPA in the nucleus tractus solitarii of spontaneously hypertensive rats.
Misu Y; Yue JL; Okumura Y; Miyamae T; Ueda H
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S34-6. PubMed ID: 9072420
[TBL] [Abstract][Full Text] [Related]
9. Altered tonic L-3,4-dihydroxyphenylalanine systems in the nucleus tractus solitarii and the rostral ventrolateral medulla of spontaneously hypertensive rats.
Yue JL; Okumura Y; Miyamae T; Ueda H; Misu Y
Neuroscience; 1995 Jul; 67(1):95-106. PubMed ID: 7477914
[TBL] [Abstract][Full Text] [Related]
10. Altered basal release and pressor effect of L-DOPA in the rostral ventrolateral medulla of spontaneously hypertensive rats.
Yue JL; Miyamae T; Ueda H; Misu Y
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S43-5. PubMed ID: 9072438
[TBL] [Abstract][Full Text] [Related]
11. Is L-DOPA a neurotransmitter of the primary baroreceptor afferents terminating in the nucleus tractus solitarii of rats?
Misu Y; Goshima Y; Yue JL; Miyamae T
Adv Pharmacol; 1998; 42():855-8. PubMed ID: 9328032
[No Abstract] [Full Text] [Related]
12. The evidence for tonic GABAergic regulation of basal L-DOPA release via activation of inhibitory GABA(A) receptors in the nucleus tractus solitarii of anesthetized rats.
Goshima Y; Honjo K; Miyamae T; Misu Y
Neurosci Lett; 1999 Feb; 261(3):155-8. PubMed ID: 10081972
[TBL] [Abstract][Full Text] [Related]
13. Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.
Iderberg H; McCreary AC; Varney MA; Cenci MA; Newman-Tancredi A
Neuropharmacology; 2015 Jun; 93():52-67. PubMed ID: 25645393
[TBL] [Abstract][Full Text] [Related]
14. Review on the relationship between nicotinic acetylcholine receptors and dopaminergic neurotransmission in the central nervous system--dopa is an endogenous neuroactive substance.
Misu Y; Nakamura S; Goshima Y; Yue JL; Miyamae T; Kubo T
Yakubutsu Seishin Kodo; 1993 Jun; 13(3):199-210. PubMed ID: 8237136
[TBL] [Abstract][Full Text] [Related]
15. The neuroregulatory properties of L-DOPA. A review of the evidence and potential role in the treatment of Parkinson's disease.
Tedroff JM
Rev Neurosci; 1997; 8(3-4):195-204. PubMed ID: 9548232
[TBL] [Abstract][Full Text] [Related]
16. Loss of tonic neuronal activity to release L-DOPA in the caudal ventrolateral medulla of spontaneously hypertensive rats.
Miyamae T; Yue JL; Okumura Y; Goshima Y; Misu Y
Neurosci Lett; 1995 Sep; 198(1):37-40. PubMed ID: 8570091
[TBL] [Abstract][Full Text] [Related]
17. Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity.
Paolone G; Brugnoli A; Arcuri L; Mercatelli D; Morari M
Mov Disord; 2015 Nov; 30(13):1728-38. PubMed ID: 26207892
[TBL] [Abstract][Full Text] [Related]
18. DOPA causes glutamate release and delayed neuron death by brain ischemia in rats.
Misu Y; Furukawa N; Arai N; Miyamae T; Goshima Y; Fujita K
Neurotoxicol Teratol; 2002; 24(5):629-38. PubMed ID: 12200194
[TBL] [Abstract][Full Text] [Related]
19. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
Suárez LM; Solís O; Caramés JM; Taravini IR; Solís JM; Murer MG; Moratalla R
Biol Psychiatry; 2014 May; 75(9):711-22. PubMed ID: 23769604
[TBL] [Abstract][Full Text] [Related]
20. Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia.
Ravenscroft P; Chalon S; Brotchie JM; Crossman AR
Exp Neurol; 2004 Jan; 185(1):36-46. PubMed ID: 14697317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
